To make the Biggest difference Table 2
FDA seeks to remove ingestible fluoride products for children
The administration has set a goal date of October 31 to complete a safety review, public comment period, and to take "appropriate action" in efforts to remove products from the market.
Food Insecurity and the Dangers of Infant Formula Dilution
FDA approves pediatric indication for Optison ultrasound enhancing agent
This FDA decision will help to improve clarity and diagnostic accuracy of echocardiograms in pediatric patients, according to GE HealthCare.
Demystifying Infant Formula
FDA clears EN-374 therapy application for X-linked chronic granulomatous disease
The in vivo hematopoietic stem cell-directed therapy received rare pediatric disease and orphan drug designations earlier this year.
Frequent perinatal antibiotic use and impaired lung function in preterm-born children
"Early identification of high-risk neonates may enable targeted strategies to support respiratory health," stated the study investigators.
